GPT and metabolic dysfunction-associated steatotic liver disease: Such an oligogenic model is consistent with recent GWAS findings, which showed that a 9-variant PRS for chronic ALT elevation, a proxy for NAFLD, had effects similar to those observed for a 77-variant PRS23.